Harvard Bioscience, Inc.HBIONASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 46.06% |
| Q2 2025 | 95.47% |
| Q1 2025 | -279766.67% |
| Q4 2024 | 100.37% |
| Q3 2024 | -64.06% |
| Q2 2024 | 37.64% |
| Q1 2024 | -158.20% |
| Q4 2023 | -46.73% |
| Q3 2023 | -26.43% |
| Q2 2023 | -257.56% |
| Q1 2023 | 137.33% |
| Q4 2022 | 51.07% |
| Q3 2022 | -239.84% |
| Q2 2022 | 135.39% |
| Q1 2022 | -815.92% |
| Q4 2021 | 665.29% |
| Q3 2021 | 58.54% |
| Q2 2021 | 38.71% |
| Q1 2021 | -8.78% |
| Q4 2020 | 43.99% |
| Q3 2020 | 30.55% |
| Q2 2020 | 64.99% |
| Q1 2020 | -921.09% |
| Q4 2019 | 120.99% |
| Q3 2019 | -960.73% |
| Q2 2019 | 89.58% |
| Q1 2019 | -202.07% |
| Q4 2018 | 1007.03% |
| Q3 2018 | 82.51% |
| Q2 2018 | 63.98% |
| Q1 2018 | -506.81% |
| Q4 2017 | 339.57% |
| Q3 2017 | -9.45% |
| Q2 2017 | 64.26% |
| Q1 2017 | 19.24% |
| Q4 2016 | 19.41% |
| Q3 2016 | -129.73% |
| Q2 2016 | -12.11% |
| Q1 2016 | 96.29% |
| Q4 2015 | -1923.61% |